Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-25T04:57:34.541Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk factors and outcomes for hyperbilirubinaemia after heart surgery in children

Published online by Cambridge University Press:  05 May 2020

Daniel M. Pasternack Open the ORCID record for Daniel M. Pasternack [Opens in a new window] ,
Manal AlQahtani ,
Rafael Zonana Amkie ,
Lisa J. Sosa ,
Marcelle Reyes  and
Jun Sasaki
Daniel M. Pasternack
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA
Manal AlQahtani
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA
Rafael Zonana Amkie
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA
Lisa J. Sosa
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA
Marcelle Reyes
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA
Jun Sasaki*
Affiliation:
Nicklaus Children’s Hospital, Miami, FL, USA Herbert Wertheim School of Medicine, Florida International University, Miami, FL, USA
*
Author for correspondence: Jun Sasaki, MD, Department of Cardiology, The Heart Program, Nicklaus Children’s Hospital, Nicklaus Children’s Health System, 3100 SW 62nd Avenue, Miami, FL33155, USA. Tel: +1 305-662-8301; Fax: +1 305-662-8304. E-mail: jun.sasaki@nicklaushealth.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Liver dysfunction, associated with morbidity and mortality, is common in patients with CHD. We investigate risk factors for and outcomes of hyperbilirubinaemia in neonates and infants after cardiac surgery.

Materials and methods:

In a retrospective analysis of neonates and infants undergoing cardiac surgery at our institution between January 2013 and December 2017, we identified those with post-operative conjugated hyperbilirubinaemia. We tested various demographic and surgical risk factors, and use of post-operative interventions, for an association with conjugated hyperbilirubinaemia. We also tested hyperbilirubinaemia for association with post-operative mortality and prolonged length of stay.

Results:

We identified 242 post-operative admissions, of which 45 (19%) had conjugated hyperbilirubinaemia. The average conjugated bilirubin level in this group was 2.0 mg/dl versus 0.3 mg/dl for peers without hyperbilirubinaemia. The post-operative use of both extracorporeal membrane oxygenation (OR 4.97, 95% CI 1.89–13.5, p = 0.001) and total parenteral nutrition (OR 2.98, 95% CI 1.34–7.17, p = 0.010) was associated with conjugated hyperbilirubinaemia. No demographic variable analysed was found to be a risk factor. Hyperbilirubinaemia was associated with higher odds of mortality (OR 3.74, 95% CI 2.69–13.8, p = 0.005) and prolonged length of stay (OR 2.87, 95% CI 2.02–7.97, p = 0.005), which were independent of other risk factors.

Discussion:

We identified the post-operative use of total parenteral nutrition and extracorporeal membrane oxygenation as risk factors for hyperbilirubinaemia. These patients were more likely to experience morbidity and mortality than control peers. As such, bilirubin may be marker for elevated risk of poor post-operative outcomes and should be more frequently measured after cardiac surgery.

Keywords

Conjugated bilirubinhyperbilirubinaemiacardiac surgerypost-operative outcomes
Type
Original Article
Information
Cardiology in the Young , Volume 30 , Issue 6 , June 2020 , pp. 761 - 768
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Denis, C, De Kerguennec, C, Bernuau, J, Beauvais, F, Cohen Solal, A.Acute hypoxic hepatitis (’liver shock’): still a frequently overlooked cardiological diagnosis. Eur J Heart Fail 2004; 6: 561–565. doi:10.1016/j.ejheart.2003.12.008CrossRefGoogle Scholar
Asrani, SK, Asrani, NS, Freese, DK, et al.Congenital heart disease and the liver. Hepatology 2012; 56: 1160–1169. doi:10.1002/hep.25692CrossRefGoogle ScholarPubMed
Alonso-Gonzalez, R.Liver dysfunction and congenital heart disease: are we ready for the epidemic? Int J Cardiol 2017; 249: 169–170. doi:10.1016/j.ijcard.2017.08.050CrossRefGoogle ScholarPubMed
Rychik, J, Veldtman, G, Rand, E, et al.The precarious state of the liver after a Fontan operation: Summary of a multidisciplinary symposium. Pediatr Cardiol 2012; 33: 1001–1012. doi:10.1007/s00246-012-0315-7CrossRefGoogle ScholarPubMed
Kavoliuniene, A, Vaitiekiene, A, Cesnaite, G.Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist’s point of view. Int J Cardiol 2013; 166: 554–558. doi:10.1016/j.ijcard.2012.05.003CrossRefGoogle ScholarPubMed
Fouad, YM, Yehia, R.Hepato-cardiac disorders. World J Hepatol 2014; 6: 41–54. doi:10.4254/wjh.v6.i1.41CrossRefGoogle ScholarPubMed
Fuhrmann, V, Jäger, B, Zubkova, A, Drolz, A.Hypoxic hepatitis – epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129–139. doi:10.1007/s00508-010-1357-6CrossRefGoogle ScholarPubMed
Waseem, N, Chen, P.Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol 2016; 4: 263–268. doi:10.14218/jcth.2016.00022Google ScholarPubMed
van Deursen, VM, Damman, K, Hillege, HL, van Beek, AP, van Veldhuisen, DJ, Voors, AA.Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 2010; 16: 84–90. doi:10.1016/j.cardfail.2009.08.002CrossRefGoogle ScholarPubMed
Asano, M, Matsumae, H, Suzuki, K, Nakai, Y, Nakayama, T, Nomura, N.Prognostic risk analyses for postcardiotomy extracorporeal membrane oxygenation in children: a review of early and intermediate outcomes. Pediatr Cardiol 2019; 40: 89–100. doi:10.1007/s00246-018-1964-yCrossRefGoogle ScholarPubMed
Gottesman, LE, Del Vecchio, MT, Aronoff, SC.Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects. BMC Pediatr 2015; 15: 1–8. doi:10.1186/s12887-015-0506-5CrossRefGoogle ScholarPubMed
Kwan, V, George, J.Liver disease due to parenteral and enteral nutrition. Clin Liver Dis 2004; 8: 893–913. doi:10.1016/j.cld.2004.06.003CrossRefGoogle ScholarPubMed
Willis, TC, Carter, BA, Rogers, SP, Hawthorne, KM, Hicks, PD, Abrams, SA.High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. J Parenter Enter Nutr 2010; 34: 32–37. doi:10.1177/0148607109332772CrossRefGoogle ScholarPubMed
Shteyer, E, Yatsiv, I, Sharkia, M, Milgarter, E, Granot, E.Serum transaminases as a prognostic factor in children post cardiac surgery. Pediatr Int 2011; 53: 725–728. doi:10.1111/j.1442-200X.2011.03356.xCrossRefGoogle ScholarPubMed
Ambrosy, AP, Vaduganathan, M, Huffman, MD, et al.Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 2012; 14: 302–311. doi:10.1093/eurjhf/hfs007CrossRefGoogle ScholarPubMed
Feldman, AG, Sokol, RJ.Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol 2019; 377: 364–377. doi:10.1038/s41575-019-0132-zGoogle Scholar
Jacquemin, E, Lykavieris, P, Chaoui, N, Hadchouel, M, Bernard, O.Transient neonatal cholestasis: Origin and outcome. J Pediatr 1998; 133: 563–567. doi:10.1016/S0022-3476(98)70070-8CrossRefGoogle ScholarPubMed
Chiou, FK, Ong, C, Phua, KB, Chedid, F, Kader, A.Conjugated hyperbilirubinemia presenting in first fourteen days in term neonates. World J Hepatol 2017; 9 1108. doi:10.4254/wjh.v9.i26.1108CrossRefGoogle ScholarPubMed
Kargl, S, Gitter, R, Pumberger, W.Cholelithiasis in children with CHD: is it a problem? Cardiol Young 2017; 27: 630–633. doi:10.1017/S1047951116000846CrossRefGoogle ScholarPubMed
Fujishiro, J, Sugiyama, M, Ishimaru, T, et al.Direct hyperbilirubinemia in infants with congenital heart disease. Pediatr Int 2018; 60: 179–182. doi:10.1111/ped.13462CrossRefGoogle ScholarPubMed
Sasaki, J, Dykes, JC, Sosa, LJ, et al.Risk factors for longer hospital stay following the Fontan operation. Pediatr Crit Care Med 2016; 17: 411–419. doi:10.1097/PCC.0000000000000701CrossRefGoogle ScholarPubMed
Kondrackiene, J, Beuers, U, Kupcinskas, L.Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005; 129: 894–901. doi:10.1053/j.gastro.2005.06.019CrossRefGoogle ScholarPubMed
O’Brien, SM, Clarke, DR, Jacobs, JP, et al.An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 2009; 138: 1139–1153. doi:10.1016/j.jtcvs.2009.03.071CrossRefGoogle ScholarPubMed
Philip, J, Samraj, RS, Lopez-Colon, D, Gonzalez-Peralta, R, Chandran, A, Bleiwies, MS.Severe direct hyperbilirubinemia as a consequence of right heart failure in congenital heart disease. World J Pediatr Congenit Heart Surg 2018; 9: 470–474. doi:10.1177/2150135116640786CrossRefGoogle ScholarPubMed